Locally advanced breast cancer: report of phase II study and subsequent phase III trial.

Twenty-four evaluable patients with stage T4 breast cancer were entered into a phase II study and received chemotherapy comprising cyclophosphamide 1,000 mg m-2 i.v., doxorubicin 50 mg m-2 i.v., vincristine 1.4 mg m-2 i.v. and prednisolone 40 mg orally for 5 days, given 3 weekly for four cycles prio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodger, A., Jack, W. J., Hardman, P. D., Kerr, G. R., Chetty, U., Leonard, R. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977400/
https://www.ncbi.nlm.nih.gov/pubmed/1586604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977400/
https://www.ncbi.nlm.nih.gov/pubmed/1586604

Ejemplares similares